Literature DB >> 10654978

Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy.

J K McGuire1, M S Kulkarni, H P Baden.   

Abstract

We report a case of fatal hypermagnesemia resulting from the unsupervised use of high doses of magnesium oxide administered as part of a regimen of megavitamin and megamineral therapy to a child with mental retardation, spastic quadriplegia, and seizures. The treatment regimen was given at the recommendation of a dietician working as a private nutritional consultant without the involvement or notification of the child's pediatrician. Hypermagnesemia is an uncommon but serious side effect of the use of magnesium containing compounds. These compounds are widely used as laxatives and dietary supplements, and serious side effects are uncommon when used in appropriate dosages and with adequate supervision. The use of alternative medical therapies, including megavitamin/megamineral therapy, is widespread. Many patients use alternative medicine or seek care from alternative medicine practitioners without the recommendation or knowledge of their primary physicians. Despite unproved benefit, many alternative therapies may be safe. However, unsupervised use of generally safe treatments can result in serious side effects. This case report serves to illustrate the characteristic pathophysiologic changes of severe hypermagnesemia, an entity rarely seen in pediatric practice, and more importantly, it alerts primary care and subspecialty pediatricians to be aware of and monitor the use of alternative medical therapies in their patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654978     DOI: 10.1542/peds.105.2.e18

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

Review 1.  Hypomagnesemia and hypermagnesemia.

Authors:  Joel Michels Topf; Patrick T Murray
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Comparison of complementary and alternative medicine use: reasons and motivations between two tertiary children's hospitals.

Authors:  D R Cincotta; N W Crawford; A Lim; N E Cranswick; S Skull; M South; C V E Powell
Journal:  Arch Dis Child       Date:  2005-09-15       Impact factor: 3.791

Review 3.  Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners.

Authors:  Elizabeth A Hurt; L Eugene Arnold; Nicholas Lofthouse
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

4.  Serum magnesium concentration in children with functional constipation treated with magnesium oxide.

Authors:  Maiko Tatsuki; Reiko Miyazawa; Takeshi Tomomasa; Takashi Ishige; Tomoko Nakazawa; Hirokazu Arakawa
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

5.  Severe hypermagnesemia presenting with abnormal electrocardiographic findings similar to those of hyperkalemia in a child undergoing peritoneal dialysis.

Authors:  Won Kyoung Jhang; Yoon Jung Lee; Young A Kim; Seong Jong Park; Young Seo Park
Journal:  Korean J Pediatr       Date:  2013-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.